<DOC>
	<DOCNO>NCT00660569</DOCNO>
	<brief_summary>The purpose study identify potential issue short mid term utilization Pulmicort hydro fluoroaklane ( HFA ) pressurize metered-dose inhaler ( pMDI ) describe associate factor .</brief_summary>
	<brief_title>Utilization Patterns Pulmicort Real Life Practice</brief_title>
	<detailed_description />
	<mesh_term>Budesonide</mesh_term>
	<criteria>Asthmatic patient diagnose least 12 month duration study inclusion Patients previously treat Pulmicort CFC change treatment Pulmicort HFA Disability , investigator point view , prevent comply follow schedule To participate clinical study past 6 month</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>asthma treatment</keyword>
	<keyword>utilization</keyword>
	<keyword>real life practice</keyword>
</DOC>